Breaking the Age Barrier: Mucinous Adenocarcinoma of the Bladder in a Young Man

Authors

  • Govardhani V
  • Kalaivani Amitkumar
  • Balaji Radhakrishnan
  • Meethu Rappai
  • Pratheepa Sivasankari Natarajan

Keywords:

Invasive Bladder adenocarcinoma, haematuria, immunohistochemistry

Abstract

Adenocarcinoma is a rare form of malignancy, representing approximately 0.5% to 2% of all bladder cancers. Approximately 90% of patients exhibit haematuria at presentation. The condition primarily affects adults, peaking in incidence during the seventh decade of life, with a higher occurrence in males. Tumors can develop throughout the urinary tract, including the bladder, urethra, renal pelvis and ureter. Due to its rarity, the underlying causes are not well understood. It has been postulated that bladder adenocarcinoma may result from malignant transformation of intestinal metaplasia in the urothelial mucosa. In our study we have diagnosed, A 24 year old male patient from West Bengal, who presented with tumor sized 3.8x3.5x3.5cm in the dome of bladder was diagnosed with primary invasive adenocarcinoma of bladder – mucinous type. The diagnostic challenge of this case that we had to thoroughly evaluate to exclude the primary from other organs like colon or prostrate. Mucinous and signet-ring cell histological patterns are extremely rare, and they are often challenging to differentiate morphologically from metastatic colorectal adenocarcinoma. Careful correlation with clinical, radiological, biopsy, staging and immunohistochemistry plays a vital role in diagnosing such rare tumor. Stage is important prognostic factor. 5 year disease free survival rate is 40-50%. Treatment is radical cystectomy followed by adjuvant therapy with chemo or radiotherapy, after excluding gastrointestinal origin primary malignancy

Downloads

Download data is not yet available.

References

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer.

Sigalas K, Tyritzis SI, Trigka E, Katafigiotis I, Kavantzas N, Stravodimos KG. A male presenting with a primary mucinous bladder carcinoma: a case report. Cases J. 2010 Feb 3;3:49. doi: 10.1186/1757-1626-3-49. PMID: 20205820; PMCID: PMC2824640.

Roy S, Smith MA, Cieply KM, Acquafondata MB, Parwani AV. Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge. Diagn Pathol. 2012 Nov 2;7: 151.

Amin MB, editor. WHO classification of tumours: Urinary and male genital tumours. International Agency for Research on Cancer; 2022.

Zaghloul MS, Nouh A, Nazmy M, et al. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol Oncol 2006;24:13-20.

Marques ML, D’Alessandro GS, Chade DC, Lanzoni VP, Saiovici S, Ramos de Almeida JR: Primary mucinous adenocarcinoma of the bladder with signet-ring cells: case report. Sao Paulo Med J. 2007;125:297-99.

Marques ML, D'Alessandro GS, Chade DC, Lanzoni VP, Saiovici S, Almeida CJ. Primary mucinous adenocarcinoma of the bladder with signet-ring cells: case report. Sao Paulo Med J. 2007 Sep 6;125(5):297-9. doi: 10.1590/s1516-31802007000500011. PMID: 18094900; PMCID: PMC11041510.

Zhang BY, Aguilar J, Yang M, et al. Mucinous metaplasia in urothelial tract may be the precancerous lesion of mucinous adenocarcinoma: report of two cases and review of literature. Int J Clin Exp Med 2014;7:285-9.

Wang D, Zhang K, Guan L, Wen N. Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review. Transl Cancer Res. 2022 Jul;11(7):2416-2424. doi: 10.21037/tcr-22-1547. PMID: 35966298; PMCID: PMC9372207.

Ghewade P, Shukla S, Vagha S, Kalode SS, Gadkari P. Primary Adenocarcinoma of the Urinary Bladder: A Case Report on a Rare Malignancy. Cureus. 2024 Aug 6;16(8):e66269. doi: 10.7759/cureus.66269. PMID: 39238745; PMCID: PMC11375912.

Singh I, Prasad R. Primary urachal mucinous adenocarcinoma of the urinary bladder. J Clin Diagn Res. 2013 May;7(5):911-3. doi: 10.7860/JCDR/2013/5597.2973. Epub 2013 May 1. PMID: 23814741; PMCID: PMC3681068.

Chang SS, Bochner BH, Chou R, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol 2017;198:552-9.

Merseburger AS, Apolo AB, Chowdhury S, et al. SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer. World J Urol 2019;37:95-105.

Vijayakumar V, Natesan G, Sudhakar M, Prakasam U, Seeralan V, Kaliyaperumal M et al. Primary Mucinous Adenocarcinoma of the Bladder: Case Report and Review of Literature. Indian J Surg Oncol. 2020 Sep;11(Suppl 1): 44-7.

Melicow MM. Tumors of the urinary bladder: a clinico-pathological analysis of over 2500 specimens and biopsies. J Urol. 1955 Oct;74(4): 498-521.

Downloads

Published

2025-06-05

How to Cite

1.
V G, Amitkumar K, Radhakrishnan B, Rappai M, Natarajan PS. Breaking the Age Barrier: Mucinous Adenocarcinoma of the Bladder in a Young Man. J Neonatal Surg [Internet]. 2025Jun.5 [cited 2025Jun.20];14(31S):228-33. Available from: https://jneonatalsurg.com/index.php/jns/article/view/7104